We narrowed to 2,195 results for: Xpa
- 
  Plasmid#198190PurposeGeneration of Expandable megakaryocyte cell lines from human iPS cellsDepositorAvailable SinceMay 8, 2023AvailabilityAcademic Institutions and Nonprofits only
- 
  Antibody#207115-rAbPurposeAnti-Beta-2-microglobulin [BBM.1] (Human) recombinant mouse monoclonal antibodyDepositorRecommended ApplicationsImmunocytochemistryReactivityHumanSource SpeciesMouseIsotypeIgG2aTrial SizeAvailable to purchaseAvailable SinceNov. 22, 2024AvailabilityIndustry, Academic Institutions, and Nonprofits  
- 
  pGL1_108Plasmid#210692PurposeLevel 1 plasmid, barcoded ORIDepositorInsertpIM13 with barcode 28
 UseSynthetic BiologyAvailable SinceDec. 15, 2023AvailabilityAcademic Institutions and Nonprofits only
- 
  pGL1_110Plasmid#210694PurposeLevel 1 plasmid, barcoded ORIDepositorInsertpTHT15 with barcode 30
 UseSynthetic BiologyAvailable SinceDec. 15, 2023AvailabilityAcademic Institutions and Nonprofits only
- 
  pGL1_109Plasmid#210693PurposeLevel 1 plasmid, barcoded ORIDepositorInsertpMB1 with barcode 29
 UseSynthetic BiologyAvailable SinceDec. 15, 2023AvailabilityAcademic Institutions and Nonprofits only
- 
  pGL1_107Plasmid#210691PurposeLevel 1 plasmid, barcoded ORIDepositorInsertpCD6 ORI with barcode 27
 UseSynthetic BiologyAvailable SinceDec. 15, 2023AvailabilityAcademic Institutions and Nonprofits only
- 
  pGL1_106Plasmid#210690PurposeLevel 1 plasmid, barcoded ORIDepositorInsertpCB102 ORI with barcode 26
 UseSynthetic BiologyAvailable SinceDec. 15, 2023AvailabilityAcademic Institutions and Nonprofits only
- 
  pGL1_105Plasmid#210689PurposeLevel 1 plasmid, barcoded ORIDepositorInsertpBP1 ORI with barcode 11
 UseSynthetic BiologyAvailable SinceDec. 18, 2023AvailabilityAcademic Institutions and Nonprofits only
- 
  pGL0_154 [pCD6 ORI]Plasmid#210676PurposeLevel 0 partDepositorInsertpCD6 ORI
 UseSynthetic BiologyAvailable SinceDec. 14, 2023AvailabilityAcademic Institutions and Nonprofits only
- 
  pGL0_153 [pCB102 ORI]Plasmid#210675PurposeLevel 0 partDepositorInsertpCB102 ORI
 UseSynthetic BiologyAvailable SinceDec. 14, 2023AvailabilityAcademic Institutions and Nonprofits only
- 
  pGL0_155 [pIM13 ORI]Plasmid#210677PurposeLevel 0 partDepositorInsertpIM13 ORI
 UseSynthetic BiologyAvailable SinceDec. 14, 2023AvailabilityAcademic Institutions and Nonprofits only
- 
  pGL0_168 [pMB1 ORI]Plasmid#210687PurposeLevel 0 partDepositorInsertpMB1 ORI
 UseSynthetic BiologyAvailable SinceDec. 15, 2023AvailabilityAcademic Institutions and Nonprofits only
- 
  pGL0_169 [pTHT15 ORI]Plasmid#210688PurposeLevel 0 partDepositorInsertpTHT15 ORI
 UseSynthetic BiologyAvailable SinceDec. 15, 2023AvailabilityAcademic Institutions and Nonprofits only
- 
  pGL0_161 [TermB]Plasmid#210683PurposeLevel 0 partDepositorInsertTermB
 UseSynthetic BiologyAvailable SinceJan. 8, 2024AvailabilityAcademic Institutions and Nonprofits only
- 
  pGL0_166 [Taad(9)]Plasmid#210686PurposeLevel 0 partDepositorInsertTaad(9)
 UseSynthetic BiologyAvailable SinceJan. 8, 2024AvailabilityAcademic Institutions and Nonprofits only
- 
  pGL0_165 [aad(9)]Plasmid#210685PurposeLevel 0 partDepositorInsertaad(9)
 UseSynthetic BiologyAvailable SinceJan. 8, 2024AvailabilityAcademic Institutions and Nonprofits only
- 
  pGL0_164 [Paad(9)]Plasmid#210684PurposeLevel 0 partDepositorInsertPaad(9)
 UseSynthetic BiologyAvailable SinceJan. 8, 2024AvailabilityAcademic Institutions and Nonprofits only
- 
  pGL0_160 [ermB]Plasmid#210682PurposeLevel 0 partDepositorInsertermB
 UseSynthetic BiologyAvailable SinceJan. 8, 2024AvailabilityAcademic Institutions and Nonprofits only
- 
  pGL0_159 [PermB]Plasmid#210681PurposeLevel 0 partDepositorInsertPermB
 UseSynthetic BiologyAvailable SinceJan. 8, 2024AvailabilityAcademic Institutions and Nonprofits only
- 
  pGL0_158 [TcatP]Plasmid#210680PurposeLevel 0 partDepositorInsertTcatP
 UseSynthetic BiologyAvailable SinceJan. 8, 2024AvailabilityAcademic Institutions and Nonprofits only
 
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
      